Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1004P is a processed pseudogene derived from the highly conserved U6 small nuclear RNA gene, an essential component of the spliceosome involved in pre-mRNA splicing in eukaryotes. Pseudogenes like RNU6-1004P are commonly found in vertebrate genomes due to historical retrotransposition events mediated by elements such as LINE-1 (L1). Unlike functional U6 snRNA, which actively participates in catalytic spliceosome assembly and intron removal, RNU6-1004P does not produce a functional RNA and is considered nonfunctional in biological processes. Although the sequence may resemble the original U6 snRNA, it generally contains mutations, truncations, or other changes that prevent normal function. Research into U6 snRNA pseudogenes helps elucidate genome structure and retrotransposon dynamics but does not support their status as druggable or therapeutic targets.
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1004, pseudogene (RNU6-1004P).